We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
-14.07%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.34B
AUM Growth
-$421M
Cap. Flow
+$11.7M
Cap. Flow %
0.5%
Top 10 Hldgs %
40.93%
Holding
221
New
9
Increased
52
Reduced
52
Closed
18

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$15.4M
2
MDT icon
Medtronic
MDT
+$13.3M
3
UNH icon
UnitedHealth
UNH
+$8.16M
4
ISRG icon
Intuitive Surgical
ISRG
+$7.42M
5
PFE icon
Pfizer
PFE
+$7.12M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$17M
2
AZN icon
AstraZeneca
AZN
+$11.3M
3
IDXX icon
Idexx Laboratories
IDXX
+$10.4M
4
VTRS icon
Viatris
VTRS
+$8.21M
5
OHI icon
Omega Healthcare
OHI
+$6.92M

Sector Composition

Rank Sector Weight
1 Healthcare 94.39%
2 Real Estate 2.48%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
76
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.17M 0.26%
63,345
+19,747
+45% +$2.59M
IMMU
77
DELISTED
Immunomedics Inc
IMMU
$6.16M 0.26%
431,527
+334,157
+343% +$6.63M
VTR icon
78
Ventas
VTR
$44.7B
$5.77M 0.25%
98,496
– –
PVLA
79
Palvella Therapeutics
PVLA
$2.15B
$5.55M 0.24%
26,092
– –
DGX icon
80
Quest Diagnostics
DGX
$25.9B
$5.54M 0.24%
66,500
+27,500
+71% +$2.58M
ENDP
81
DELISTED
Endo International plc
ENDP
$5.24M 0.22%
717,274
-301,774
-30% -$4.14M
ARRY
82
DELISTED
Array Biopharma Inc
ARRY
$5.19M 0.22%
364,166
– –
MRUS
83
DELISTED
Merus
MRUS
$5.15M 0.22%
367,671
-46,444
-11% -$672K
STE icon
84
Steris
STE
$22.5B
$5.13M 0.22%
48,003
+12,800
+36% +$1.43M
CRSP icon
85
CRISPR Therapeutics
CRSP
$4.77B
$5.09M 0.22%
178,348
– –
XRAY icon
86
Dentsply Sirona
XRAY
$2.75B
$4.67M 0.2%
125,625
+68,025
+118% +$2.48M
IQV icon
87
IQVIA
IQV
$39.1B
$4.54M 0.19%
39,100
+22,300
+133% +$2.7M
UTHR icon
88
United Therapeutics
UTHR
$26.2B
$4.49M 0.19%
41,261
– –
IONS icon
89
Ionis Pharmaceuticals
IONS
$8.81B
$4.48M 0.19%
82,838
– –
ALKS icon
90
Alkermes
ALKS
$8.39B
$4.46M 0.19%
151,283
-19,759
-12% -$728K
ACHC icon
91
Acadia Healthcare
ACHC
$2.62B
$4.45M 0.19%
173,155
-99,245
-36% -$3.44M
DHC
92
Diversified Healthcare Trust
DHC
$2.17B
$4.42M 0.19%
377,220
-269,334
-42% -$4M
ANAB icon
93
AnaptysBio
ANAB
$1.63B
$4.2M 0.18%
65,845
+19,935
+43% +$1.48M
ZGNX
94
DELISTED
Zogenix, Inc.
ZGNX
$4.05M 0.17%
111,025
+44,843
+68% +$1.84M
ABMD
95
DELISTED
Abiomed Inc
ABMD
$4.01M 0.17%
12,350
+8,600
+229% +$2.99M
CLLS
96
Cellectis
CLLS
$287M
$3.94M 0.17%
236,530
-42,458
-15% -$984K
GBT
97
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.86M 0.17%
93,924
-38,346
-29% -$1.44M
LH icon
98
Labcorp
LH
$25.9B
$3.68M 0.16%
33,872
+19,671
+139% +$2.64M
WMGI
99
DELISTED
Wright Medical Group Inc
WMGI
$3.63M 0.16%
133,391
-133,390
-50% -$3.69M
LGND icon
100
Ligand Pharmaceuticals
LGND
$5.94B
$3.59M 0.15%
42,399
+28,068
+196% +$2.99M
2 3
4
5 6

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Tekla Capital Management held 221 positions worth $2.34B, down 15% from $2.76B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Tekla Capital Management's Q4 2018 filing shows 9 new, 52 increased, 52 reduced and 18 closed positions. Its largest new stake was Wellcare Health Plans, Inc.: 13,000 shares worth $3.07M. The largest sale was Aetna Inc, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Real Estate and Financials.

  • Tekla Capital Management's largest Q4 2018 buy was Wellcare Health Plans, Inc.: 13,000 shares worth $3.07M.
  • Tekla Capital Management added most to Bristol-Myers Squibb in Q4 2018, an estimated $15.4M increase.
  • Tekla Capital Management's biggest Q4 2018 reduction was AstraZeneca, cutting an estimated $11.3M.
  • Tekla Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $17M.
  • Tekla Capital Management's ten largest holdings make up 41% of its $2.34B portfolio in Q4 2018.
  • Tekla Capital Management opened 9 new positions and closed 18 in Q4 2018.
  • Tekla Capital Management's portfolio value fell 15% quarter-over-quarter to $2.34B.

Based on Tekla Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.